Buprenorphine Hcl 70518-2226
Product NDC
70518-2226- Manufacturer
- Remedyrepack Inc.
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- July 19, 2019
- Listing Expires
- December 31, 2027
- Application
- ANDA078633
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 2 mg/1 |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Packaging Options(1)
30 TABLET in 1 BLISTER PACK (70518-2226-0)